Research Article| Volume 171, ISSUE 2, P368-371, December 2013

Download started.


Comparison of serum anti-Mullerian hormone levels following hysterectomy and myomectomy for benign gynaecological conditions

Published:October 16, 2013DOI:



      To compare serum anti-Mullerian hormone (AMH) levels following hysterectomy and myomectomy.

      Study design

      Prospective longitudinal observational study. Serum AMH, follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels were measured pre-operatively (T1) and 2 days (T2) and 3 months (T3) following hysterectomy and myomectomy in 70 women aged 36–45 years. Hysterectomy (laparoscopy-assisted vaginal hysterectomy = 10; total abdominal hysterectomy = 25) with conservation of both ovaries for benign diseases of the uterus was performed in 35 women, and myomectomy (laparoscopy myomectomy = 15; open myomectomy = 20) was performed in another 35 women. The follow-up period was 3 months following surgery. The results were analysed using the t-test or one-way analysis of variance by repeated-measures ANOVA.


      Serum AMH in the hysterectomy group was 1.08 ± 0.77 ng/ml at T1, 0.78 ± 0.58 ng/ml at T2 and 0.81 ± 0.58 ng/ml at T3; the level was significantly lower at T2 and T3 compared with T1. In the myomectomy group, the corresponding values were 1.54 ± 0.95 ng/ml, 1.18 ± 0.77 ng/ml and 1.50 ± 0.58 ng/ml; serum AMH was significantly lower at T2 compared with T1, but the difference between T3 and T1 was not significant. There were no significant differences in serum FSH and LH in either group between these three time points.


      Serum AMH was significantly lower 2 days and 3 months following hysterectomy compared with the pre-operative level. Following myomectomy, serum AMH was significantly lower than the pre-operative level 2 days following the procedure, but was similar to the pre-operative level 3 months after surgery. Therefore, hysterectomy may have a more lasting adverse effect on ovarian reserve than myomectomy. A long-term study of AMH levels is needed.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Siddle N.
        • Sarrel P.
        • Whitehead M.
        The effect of hysterectomy on age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature review.
        Fertil Steril. 1987; 47: 94-100
        • Riedel H.H.
        • Lehmann-Willenbrock E.
        • Semm K.
        Ovarian failure phenomena after hysterectomy.
        J Reprod Med. 1986; 31: 597-600
        • Derksen J.G.
        • Brolmann H.A.
        • Wiegerinck M.A.
        • Vader H.L.
        • Heintz A.P.
        The effect of hysterectomy and endometrial ablation on follicle stimulating hormone (FSH) levels up to 1 year after surgery.
        Maturitas. 1998; 29: 133-138
        • Kaiser R.
        • Kusche M.
        • Wurz H.
        Hormone levels in women after hysterectomy.
        Arch Gynecol Obstet. 1989; 244: 169-173
        • Cooper G.S.
        • Thorp Jr., J.M.
        FSH levels in relation to hysterectomy and to unilateral oophorectomy.
        Obstet Gynecol. 1999; 94: 969-972
        • Chalmers C.
        • Lindsay M.
        • Usher D.
        • Warner P.
        • Evans D.
        • Ferguson M.
        Hysterectomy and ovarian function: levels of follicle stimulating hormone and incidence of menopausal symptoms are not affected by hysterectomy in women under age 45 years.
        Climateric. 2002; 5: 366-373
        • Metcalf M.G.
        • Braiden V.
        Retention of normal ovarian function after hysterectomy.
        J Endocrinol. 1992; 135: 597-602
        • Ernest C.W.
        • Ng H.Y.
        • Ho P.C.
        Ovarian changes after abdominal hysterectomy for benign condictions.
        J Soc Gyncol Investig. 2005; 12: 54-57
        • van Rooij I.A.
        • Tonkelaar I.
        • Broekmans F.J.
        • et al.
        Anti-Mullerian hormone is a promising predictor for the occurrence of the menopausal transition.
        Menopause. 2004; 11: 601-606
        • De Vet A.
        • Laven J.S.
        • de Jong F.H.
        • Themmen A.P.
        • Fauser B.C.
        AntiMullerian hormone serum levels: a putative marker for ovarian aging.
        Fertil Steril. 2002; 77: 357-362
        • Cook C.L.
        • Siow Y.
        • Taylor S.
        • Fallat M.E.
        Serum Mullerian-inhibiting substance levels during normal menstrual cycles.
        Fertil Steril. 2000; 73: 859-861
        • Hehenkamp W.J.
        • Looman C.W.
        • Themmen A.P.
        • de Jong F.H.
        • te Velde E.R.
        • Broekmans F.J.
        Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation.
        J Clin Endocrinol Metab. 2006; 91: 4057-4063
        • Van Rooij I.A.
        • Broekmans F.J.
        • te Velde E.R.
        • et al.
        Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve.
        Hum Reprod. 2002; 17: 3065-3071
        • Hu X.
        • Huang L.
        • Sbi Y.
        The effect of hysterectomy on ovarian blood supply and endocrine function.
        Climacteric. 2006; 9: 283-289
        • Iwase A.
        • Hirokawa W.
        • Goto M.
        • et al.
        Serum anti-Mullerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve.
        Fertil Steril. 2010; 94: 2846-2849
        • Cela V.
        • Freschi L.
        • Simi G.
        • et al.
        Fertility and endocrine outcome after robot-assisted laparoscopic myomectomy (RALM).
        Gynecol Endocrinol. 2013; 29: 79-82
        • Wouter J.K.
        • Nicole A.
        • Frank J.M.
        Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy.
        Hum Reprod. 2007; 22: 1996-2005
        • Van Rooij I.A.
        • Broekmans F.J.
        • Scheffer G.J.
        • et al.
        Serum antiMullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study.
        Fertil Steril. 2005; 83: 979-987
        • Atabekoglu C.
        • Taskm S.
        • Kabraman K.
        • Gemici A.
        • Taskin E.A.
        The effect of total abdominal hysterectomy on serum anti-Mullerian hormone levels: a pilot study.
        Climacteric. 2012; 15: 393-397
        • Lee D.Y.
        • Park H.J.
        • Kim B.G.
        • Bae D.S.
        • Yoon B.K.
        • Choi D.S.
        Change in the ovarian environment after hysterectomy as assessed by ovarian arterial blood flow indices and serum anti-Mullerian hormone levels.
        Eur J Obstet Gynecol Reprod Biol. 2010; 151: 82-85
        • Bancsi L.F.
        • Broekmans F.J.
        • Mol B.W.
        • Habbema J.D.
        • Velde E.R.
        Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis.
        Fertil Steril. 2003; 79: 1091-1100